Physician profile

Douglas C Harrington

Obstetrics & Gynecology · Pekin, IL

NPI 1598736837

$1,976.76

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,689.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $1,689.67 2023 Da Vinci Surgical System
Abbvie INC. $100.12 2019-2020
Allergan, INC. $56.32 2019
Therapeuticsmd, INC. $25.92 2019
Roche Diagnostics Corporation $24.94 2019
Amag Pharmaceuticals, INC. $23.80 2019
Daiichi Sankyo INC. $15.82 2019
Amgen INC. $15.18 2019
Becton, Dickinson and Company $13.99 2019
Merck Sharp & Dohme LLC $11.00 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Douglas C Harrington

$1,976.76

in general payments reported 2019-2025

Years
2019-2023
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/208533/douglas-c-harrington

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.